Cord Blood America CEO Matthew Schissler to Appear on Webcast to Discuss Third Quarter Financial Results.
LOS ANGELES, Nov. 20 /PRNewswire-FirstCall/ -- Cord Blood America, Inc. (BULLETIN BOARD: CBAI) , the umbilical cord blood stem cell preservation company (http://www.cordblood-america.com/ ) focused on bringing the life saving potential of stem cells to families nationwide and internationally, announced today that its CEO, Matthew Schissler, will appear on...

Cord Blood America Announces Record Revenues in Third Quarter; Second Straight Quarter With Revenues Topping $1 Million.
LOS ANGELES, Nov. 15 /PRNewswire-FirstCall/ -- Cord Blood America, Inc. (BULLETIN BOARD: CBAI) , the umbilical cord blood stem cell preservation company (http://www.cordblood-america.com/) focused on bringing the life saving potential of stem cells to families nationwide and internationally, announced today revenues for the third quarter ended September 30, 2006,...

Histostem, Apollo tie up to offer stem cell therapy.
Byline: Jeetha D'Silva MUMBAI: Histostem, a US-based company specialising in chord blood stem cell banking and stem cell therapy, and Apollo Hospitals will be entering into an agreement to offer stem cell therapy in India. In an e-mail interview with ET, Histostem's president and CEO...

The spa:do it naturally.
Byline: Sudeshna Chatterjea TIME FOR A FACT CHECK Alfalfa contains one-and-a-half times more protein than wheat and rice. Flax seeds aid in weight loss. Wheat grass can counter the adverse effects of sunstroke. According to Mumbai-based naturopath Uday Chotai, these food items are available in...

Williams Hematology (7th edition).
[ILLUSTRATION OMITTED] Williams Hematology (7th edition) by Ernest Beutler (M.D.), Marshall A. Lichtman (M.D.), Barry S. Coller (M.D.), Thomas J. Kipps (M.D.) and Uri Seligsohn (M.D.), McGraw-Hill Professional, RRP $215.00 (+ shipping) : ISBN 978-0-07143-591-8 Williams Hematology 7th Edition, addresses the hottest topics in hematology...

Pharming Announces Financing and Strategic Repositioning.
LEIDEN, Netherlands, July 31 /PRNewswire/ -- Pharming Group N.V. (EASDAQ: PHAR / Euronext: PHAR) has reached an agreement on a EUR 15 million financing facility. The facility consists of debt financing secured against certain tangible assets and is the first step in executing the company's financing strategy,...

Baxter to Further Increase Manufacturing Capacity for Therapeutic Proteins.
DEERFIELD, Ill., July 12 /PRNewswire/ -- Baxter International Inc. (NYSE: BAX) announced today that it will invest an additional $70 million to further expand and upgrade its BioScience facilities in California, Michigan, Italy, Belgium and Austria. The expansions will provide greater flexibility in manufacturing and will increase...

Maret Pharmaceuticals Appoints Leonard R. Borrmann, Pharm.D., as Chief Executive Officer.
NEWPORT BEACH, Calif., Feb. 22 /PRNewswire/ -- Maret Pharmaceuticals today announced the appointment of Leonard R. Borrmann, Pharm.D., as President and Chief Executive Officer. Dr. Borrmannn brings to Maret 18 years of experience in the pharmaceutical and biotechnology industries, most recently at ACADIA Pharmaceuticals, where he served...

European Orphan Drug Designation For Recombinant Human C1 Inhibitor Granted to Pharming.
LEIDEN, Netherlands, June 15 /PRNewswire/ -- Pharming Group N.V. announces that the European Medicine Evaluation Agency has granted the designation of Orphan Medicinal Product to recombinant human C1 inhibitor for the indication of angioedema. The European regulation for Orphan drugs was established in 1999 and is intended...

Pharming Completes Acquisition of ProBio, Inc.
LEIDEN, Netherlands, April 3 /PRNewswire/ -- Pharming Group N.V. (AEX: PHAR; Nasdaq Europe) ("Pharming") has completed the acquisition of ProBio, Inc. ("ProBio"), a US-based provider of intellectual property rights to key nuclear transfer, transgenic, and reproductive technologies (Pharming press release dated November 28, 2000). No...